Reproductive and Developmental Biology

The Korean Society of Animal Reproduction (한국동물번식학회)
권호 표지

Identification and Characterization of a KDR-positive Mesoderm Population Derived from Human Embryonic Stem Cells Post BMP4 Treatment

BMP4 처리에 의한 인간 배아줄기세포 유래 KDR 양성 중배엽성 세포군의 분화 양상 조사

  • Kim, Jung-Mo (Graduate School of Life Science, CHA Stem Cell Institute, CHA University, College of Medicine) ;
  • Son, On-Ju (Graduate School of Life Science, CHA Stem Cell Institute, CHA University, College of Medicine) ;
  • Cho, Youn-Jeong (Graduate School of Life Science, CHA Stem Cell Institute, CHA University, College of Medicine) ;
  • Lee, Jae-Ho (CHA Biotech & Diostech Co., Ltd.) ;
  • Chung, Hyung-Min (Graduate School of Life Science, CHA Stem Cell Institute, CHA University, College of Medicine)
  • 김정모 (차의과학대학 의생명과학대학원 줄기세포 연구실) ;
  • 손온주 (차의과학대학 의생명과학대학원 줄기세포 연구실) ;
  • 조윤정 (차의과학대학 의생명과학대학원 줄기세포 연구실) ;
  • 이재호 (차바이오앤디오스텍) ;
  • 정형민 (차의과학대학 의생명과학대학원 줄기세포 연구실)
  • Received : 2010.11.04
  • Accepted : 2011.01.03
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The functional cardiovascular system is comprised of distinct mesoderm-derived lineages including endothelial cells, vascular smooth muscle cells and other mesenchymal cells. Recent studies in the human embryonic stem cell differentiation model have provided evidence indicating that these cell lineages are developed from the common progenitors such as hemangioblasts and cardiovascular progenitor cells. Also, the studies have suggested that these progenitors have a common primordial progenitor, which expresses KDR (human Flk-1, also known as VEGFR2, CD309). We demonstrate here that sustained activation of BMP4 (bone morphogenetic protein 4) in hESC line, CHA15 hESC results in $KDR^+$ mesoderm specific differentiation. To determine whether the $KDR^+$ population derived from hESCs enhances potential to differentiate along multipotential mesodermal lineages than undifferentiated hESCs, we analyzed the development of the mesodermal cell types in human embryonic stem cell differentiation cultures. In embryoid body (EB) differentiation culture conditions, we identified an increased expression of $KDR^+$ population from BMP4-stimulated hESC-derived EBs. After induction with additional growth factors, the $KDR^+$ population sorted from hESCs-derived EBs displays mesenchymal, endothelial and vascular smooth muscle potential in matrix-coated monolayer culture systems. The populations plated in monolayer cultures expressed increased levels of related markers and exhibit a stable/homologous phenotype in culture terms. In conclusion, we demonstrate that the $KDR^+$ population is stably isolated from CHA15 hESC-derived EBs using BMP4 and growth factors, and sorted $KDR^+$ population can be utilized to generate multipotential mesodermal progenitors in vitro, which can be further differentiated into cardiovascular specific cells.

Keywords

References

  1. Bai H, Gao Y, Arzigian M, Wojchowski DM, Wu WS, Wang ZZ (2010): BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J Cell Biochem 109:363-374.
  2. Bai H, Wang ZZ (2008): Directing human embryonic stem cells to generate vascular progenitor cells. Gene Ther 15:89-95. https://doi.org/10.1038/sj.gt.3303005
  3. Boyd NL, Dhara SK, Rekaya R, Godbey EA, Hasneen K, Rao RR, West FD, 3rd, Gerwe BA, Stice SL (2007): BMP4 promotes formation of primitive vascular networks in human embryonic stern cell-derived embryoid bodies. Exp BioI Med (Maywood) 232:833-843.
  4. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM (2007): Improvement of postnatal neovascularization by human embryonic stern cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116:2409-2419. https://doi.org/10.1161/CIRCULATIONAHA.106.687038
  5. Choi JH, Ryu YS, Kim KH, Lee YR, Cha KW, Han IS, Kwon BS (2009): In vitro development of a hemangioblast from a human embryonic stern cell, SNUhES#3. Life Sci 85:39-45. https://doi.org/10.1016/j.lfs.2009.04.008
  6. Draper JS, Andrews PW (2002): Embryonic stem cells: advances toward potential therapeutic use. Curr Opin Obstet Gynecol 14:309-315. https://doi.org/10.1097/00001703-200206000-00011
  7. Galat V, Ozen R, Verlinskii I, Greiss H, Krotova E, Mazepa A, Chailakhian LM, Iannaccone P (2010): [Cell engineering and genetic approaches to the development of models of human embryonic stem cells for studying genetic disorders]. Biofizika 55:481-485.
  8. Gerecht-Nir S, Itskovitz-Eldor J (2004): Cell therapy using human embryonic stem cells. Transpl Immunol 12:203-209. https://doi.org/10.1016/j.trim.2003.12.013
  9. Goldman O, Feraud O, Boyer-Di Ponio J, Driancourt C, Clay D, Le Bousse-Kerdiles MC, Bennaceur-Griscelli A, Uzan G (2009): A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27:1750-1759. https://doi.org/10.1002/stem.100
  10. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S (2002): Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642. https://doi.org/10.1038/nature01245
  11. Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, Kaufman DS (2010): Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol 38:246-257 e241. https://doi.org/10.1016/j.exphem.2010.01.001
  12. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001): Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716-10721. https://doi.org/10.1073/pnas.191362598
  13. Kim J, Moon SH, Lee SH, Lee DR, Koh GY, Chung HM (2007): Effective isolation and culture of endothelial cells in embryoid body differentiated from human embryonic stem cells. Stem Cells Dev 16: 269-280. https://doi.org/10.1089/scd.2006.0108
  14. Kim J, Moon SH, Lee MJ, Oh IR, Shin JM, Park SJ, Chung SH, Kim MK, Lee KI, Chung HM (2008): Optimized condition to culture of endothelial precursor cells derived from human embyonic stern cells. Tissue Engineering and Regenerative Medicine 5:467-473.
  15. Lee JE, Kang MS, Park MH, Shim SH, Yoon TK, Chung HM, Lee DR (2010): Evaluation of 28 human stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes. Cell Transplant.
  16. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R (2002): Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391-4396. https://doi.org/10.1073/pnas.032074999
  17. Li M, Cui T, Mills DK, Lvov YM, McShane MJ (2005): Comparison of selective attachment and growth of smooth muscle cells on gelatin- and fibronectin-coated micropatterns. J Nanosci Nanotechnol 5:1809-1815. https://doi.org/10.1166/jnn.2005.436
  18. Li Z, Han Z, Wu JC (2009): Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem 106:194-199. https://doi.org/10.1002/jcb.22003
  19. Liang H, Matzkies M, Schunkert H, Tang M, Bonnemeier H, Hescheler J, Reppel M (2010): Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cell Physiol Biochem 25:459-466. https://doi.org/10.1159/000303051
  20. Lu SJ, Feng Q Caballero S, Chen Y, Moore MA, Grant MB, Lanza R (2007): Generation of functional hemangioblasts from human embryonic stern cells. Nat Methods 4:501-509. https://doi.org/10.1038/nmeth1041
  21. Murry CE, Keller G (2008): Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661-680. https://doi.org/10.1016/j.cell.2008.02.008
  22. Musunuru K, Domian IJ, Chien KR (2010): Stem cell models of cardiac development and disease. Annu Rev Cell Dev BioI 26:667-687. https://doi.org/10.1146/annurev-cellbio-100109-103948
  23. Okita K, Yamanaka S (2006): Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 1:103-111. https://doi.org/10.2174/157488806775269061
  24. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S (2000): Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958.
  25. Rufaihah AJ Haider HK Heng BC, Ye L, Tan RS, Toh WS, Tian XF, Sim EK Cao T (2010): Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair. Regen Med 5:231-244. https://doi.org/10.2217/rme.09.83
  26. Sefcik LS, Neal RA, Kaszuba SN, Parker AM, Katz AJ, Ogle RC, Botchwey EA (2008): Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic differentiation of human adipose stem cells. J Tissue Eng Regen Med 2:210-220. https://doi.org/10.1002/term.85
  27. Shannon TA (2001): Human embryonic stem cell therapy. Theol Stud 62:811-824.
  28. Sieveking DP, Ng MK (2009): Cell therapies for thera-peutic angiogenesis: back to the bench. Vasc Med 14: 153-166. https://doi.org/10.1177/1358863X08098698
  29. Taha MF, Valojerdi MR, Mowla SJ (2007): Effect of bone morphogenetic protein-4 (BMP-4) on cardiomyocyte differentiation from mouse embryonic stem cell. Int J Cardiol 120:92-101. https://doi.org/10.1016/j.ijcard.2006.08.118
  30. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998): Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. https://doi.org/10.1126/science.282.5391.1145
  31. Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, Martin T, Rouleau A, Bhatia M (2004): Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21:31-41. https://doi.org/10.1016/j.immuni.2004.06.006
  32. Xie CQ Zhang J, Villacorta L, Cui T, Huang H, Chen YE (2007): A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc BioI 27:e311-312. https://doi.org/10.1161/ATVBAHA.107.154260
  33. Yamahara K, Itoh H (2009): Potential use of endothelial progenitor cells for regeneration of the vasculature. Ther Adv Cardiovasc Dis 3:17-27. https://doi.org/10.1177/1753944708097728
  34. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LT, Keller GM (2008): Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528. https://doi.org/10.1038/nature06894
  35. Zeevi-Levin N, Itskovitz-Eldor J, Binah O (2010): Functional properties of human embryonic stem cell-derived cardiomyocytes. Crit Rev Eukaryot Gene Expr 20:51-59. https://doi.org/10.1615/CritRevEukarGeneExpr.v20.i1.40
  36. Zeng X. Rao MS (2006): The therapeutic potential of embryonic stem cells: A focus on stem cell stability. Curr Opin Mol Ther 8:338-344.
  37. Zhang P, Li J, Tan Z, Wang C, Liu T, Chen L, Yong J, Jiang W, Sun X, Du L, Ding M, Deng H (2008): Short-term BMP-4 treatment initiates mesoderm induclion in human embryonic stem cells. Blood 111:1933-1941. https://doi.org/10.1182/blood-2007-02-074120